Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01638455 · ClinicalTrials.gov registry record · NA

Pulse CO-Oximetry Noninvasive Monitoring and Laboratory Measurements of Subject Blood Samples

A NA study, sponsored by Masimo Corporation.

Completed
Registry status
NA
Development phase
2,776
Enrollment target

NCT01638455: Completed NA study, sponsored by Masimo Corporation.

NCT01638455 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 2,776 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01638455, a NA study, has completed, sponsored by Masimo Corporation.

COMPLETED
Registry status
NA
Development phase
2,776 participants
Enrollment target

Study Summary

Characterize Masimo noninvasive technology in spot check reading on subjects and make comparison to invasive blood sampling tested on reference analyzers.

Interventions

  • DEVICE Noninvasive device

Trial Details

FieldValue
Enrollment Target 2,776 participants
Start Date 2012-06
Est. Completion 2016-09-07
Phase NA
Masimo Corporation

96 total trials

What the finished NCT01638455 record still lists

NCT01638455 is an interventional study that assigns participants to a tested intervention. Its 2,776 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% higher).

The record links to 0 conditions, and to 1 intervention - of which Noninvasive device is the first listed.

NCT01638455 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01638455 about?

NCT01638455 is a clinical study titled "Pulse CO-Oximetry Noninvasive Monitoring and Laboratory Measurements of Subject Blood Samples". Characterize Masimo noninvasive technology in spot check reading on subjects and make comparison to invasive blood sampling tested on reference analyzers.

What is the current status of trial NCT01638455?

This trial is currently completed. It is a NA study. The enrollment target is 2,776 participants. The study started on 2012-06. Estimated completion is 2016-09-07.

What interventions are being tested in trial NCT01638455?

The interventions under investigation include: Noninvasive device (DEVICE).

Who is sponsoring clinical trial NCT01638455?

This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01638455's enrollment target sits among peer trials

2,776 44th of 2000 higher than 1,957 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05443737 · 2,800 participants · Phase 3

    Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients

  • NCT05899439 · 2,800 participants

    Immune Function and the Progression to T1D

  • NCT06089109 · 2,800 participants · NA

    Creating VIP Corps to Reduce Maternal Deaths

  • NCT06345339 · 2,800 participants · Phase 2

    A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01638455, the US trial registry maintained by the National Library of Medicine. NCT01638455 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.